Transplant patients get new hope against facial skin cancer
NCT ID NCT05860881
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 27 times
Summary
This study tests a cream containing sirolimus, applied nightly for 24 weeks, to prevent skin cancer on the face of organ transplant recipients. 146 adults who have had an organ transplant and a past skin cancer are participating. The cream is compared to a placebo to see if it reduces new skin cancers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SKIN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Princess Alexandra Hospital
Woolloongabba, Queensland, 4102, Australia
-
Royal Prince Alfred Hospital
Camperdown, New South Wales, 2050, Australia
-
Skin Health Institute
Carlton, Victoria, 3053, Australia
-
The Alfred Hospital
Melbourne, Victoria, 3004, Australia
-
The Prince Charles Hospital
Chermside, Queensland, 4032, Australia
-
Westmead Hospital
Westmead, New South Wales, 2145, Australia
Conditions
Explore the condition pages connected to this study.